These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2492869)

  • 21. Serum sulfhydryl levels in rheumatoid patients treated with gold thiomalate and penicillamine.
    Haataja M; Nissilä M; Ruutsalo HM
    Scand J Rheumatol; 1978; 7(4):212-4. PubMed ID: 104378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A method of comparing the toxicities of disease suppressive agents: possible application to a comparison between D-penicillamine and chloroquine.
    Redda A; Anastassiades T
    Clin Invest Med; 1984; 7(1):65-71. PubMed ID: 6426836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haematuria occurring during antirheumatoid therapy.
    White EG; Smith DH; Zaphiropoulos GC
    Br J Rheumatol; 1984 Feb; 23(1):57-60. PubMed ID: 6697073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
    Wooley PH; Griffin J; Panayi GS; Batchelor JR; Welsh KI; Gibson TJ
    N Engl J Med; 1980 Aug; 303(6):300-2. PubMed ID: 6770269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do penicillamine and Myocrisin act the same way in rheumatoid arthritis?
    Munthe E; Jellum E; Aaseth J
    Rheumatol Rehabil; 1978; Suppl():105-8. PubMed ID: 103179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rheumatoid arthritis V: therapy with remission-inducing agents.
    Gaines LM
    Md State Med J; 1982 Sep; 31(9):49-50. PubMed ID: 6815385
    [No Abstract]   [Full Text] [Related]  

  • 27. Remission-inducing drugs in rheumatoid arthritis.
    Anastassiades TP
    Can Med Assoc J; 1980 Feb; 122(4):405-15. PubMed ID: 6768438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drugs in the management of rheumatoid arthritis.
    Bresnihan B
    Ir Med J; 1982 Jan; 75(1):7-9. PubMed ID: 6806208
    [No Abstract]   [Full Text] [Related]  

  • 29. Sulphasalazine in rheumatoid arthritis: combination therapy with D-penicillamine or sodium aurothiomalate.
    Farr M; Kitas G; Bacon PA
    Clin Rheumatol; 1988 Jun; 7(2):242-8. PubMed ID: 2901303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of penicillamine and gold treatment in early rheumatoid arthritis.
    Mäkisara P; Nissilä M; Kajander A; Martio J; von Essen R; Anttila P; Mäkisara GL
    Scand J Rheumatol; 1978; 7(3):166-70. PubMed ID: 103190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA antigens and adverse drug reactions to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
    Dahlqvist SR; Ström H; Bjelle A; Möller E
    Clin Rheumatol; 1985 Mar; 4(1):55-61. PubMed ID: 3157529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence that D-penicillamine alters the course of rheumatoid arthritis.
    Gibson T; Huskisson EC; Wojtulewski JA; Scott PJ; Balme HW; Burry HC; Grahame R; Hart FD
    Rheumatol Rehabil; 1976 Aug; 15(3):211-5. PubMed ID: 823633
    [No Abstract]   [Full Text] [Related]  

  • 33. [Gold compounds and D-penicillamine for therapy of rheumatoid arthritis].
    Miyamoto S; Inoue T
    Nihon Rinsho; 1992 Mar; 50(3):515-20. PubMed ID: 1588740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gold sodium thiomalate and D-penicillamine. A controlled, comparative study in patients with pauciarticular and polyarticular juvenile rheumatoid arthritis.
    Kvien TK; Høyeraal HM; Sandstad B
    Scand J Rheumatol; 1985; 14(4):346-54. PubMed ID: 3936167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Slow acting anti-rheumatic drugs in the treatment of rheumatoid arthritis.
    Kovarsky J
    Tex Med; 1985 Sep; 81(9):35-9. PubMed ID: 3931276
    [No Abstract]   [Full Text] [Related]  

  • 36. [New diagnostic standards in rheumatoid arthritis and recent trends in drug therapy].
    Kashiwagi H
    Nihon Naika Gakkai Zasshi; 1990 Mar; 79(3):334-7. PubMed ID: 2110235
    [No Abstract]   [Full Text] [Related]  

  • 37. Does second-line therapy affect the radiological progression of rheumatoid arthritis?
    Pullar T; Hunter JA; Capell HA
    Ann Rheum Dis; 1984 Feb; 43(1):18-23. PubMed ID: 6421253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased pokeweed mitogen-induced IgM and IgM rheumatoid factor synthesis in rheumatoid arthritis patients treated with gold sodium thiomalate or penicillamine.
    Olsen NJ; Jasin HE
    Arthritis Rheum; 1984 Sep; 27(9):985-94. PubMed ID: 6433938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of long-term aurothiomalate and D-penicillamine treatments on renal function and urinary excretion of prostanoids in patients with rheumatoid arthritis.
    Seppälä E; Lehtinen K; Isomäki H; Nissilä M; Harmoinen A; Mörsky P; Koivula T; Vapaatalo H
    Int J Clin Pharmacol Res; 1988; 8(3):149-56. PubMed ID: 3136089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis during treatment with high-dosage D-penicillamine.
    Sadjadi SA; Seelig MS; Berger AR; Milstoc M
    Am J Nephrol; 1985; 5(3):212-6. PubMed ID: 4014326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.